Abstract:Objectives Diabetic patients continued to develop vascular complications despite achieving normal glucose level, suggesting metabolic memory which was associated with histone H3 lysine (H3K9) methylation through gene repression. Here we hypothesised that H3K9 di-methylation (H3K9me2) might be involved in vascular remodelling under diabetic condition; and histone demethylase KDM3A, an important regulator for H3K9me2, might play a key role in these pathologies. Methods To generate diabetic model, male SD rats were fed with 60% fat diet for 4 weeks followed by intraperitoneal injection with 40mg/kg streptozotocin for another 2 weeks. The carotid arteries from diabetic rats (glucose 15-33 mM) were injured by balloon catheter to induced neointimal hyperplasia, and transfected with adenovirus encoding KDM3A gene or control adenovirus (Ad-GFP) for KDM3A overexpression. A KDM3A siRNA was delivered by lentivirus to down-regulate KDM3A level; the control lentivirus is Lenti-NC. Vascular smooth muscle cells (VSMCs) were isolated from thoracic aorta of SD rats. Microarray analysis was performed to identify altered gene profile in carotid arteries after balloon injury. Chip assay was used to evaluate the H3K9me2 level at the promoter region of certain genes. Results H3K9me2 level was decreased by 51.3% in carotid arteries from diabetic rats compared to normal rats, which was associated with 1.32-fold increase of KDM3A mRNA during neointimal formation. After 28-day balloon injury, the area of neointimal to media (I/M) ratio was further enhanced by KDM3A overexpression compared with Ad-GFP control group (1.58 ± 0.30 vs. 0.86 ± 0.13, p < 0.05). However, KDM3A knockdown significantly decreased I/M ratio as compared to Lenti-NC (0.64 ± 0.18 vs. 1.45 ± 0.19, p < 0.05). Microarray analysis revealed ROCK2- and AGTR1-dependent vascular remodelling pathways was mediated by KDM3A after balloon injury at 7 days. KDM3A, ROCK2 and AGTR1 were up-regulated 4.17-fold, 1.57-fold, 4.14-fold, respectively, in KDM3A overexpression group as compared to Ad-GFP; whereas KDM3A knockdown reduced the expression of these 3 genes by 42.5%, 21.3%, 28.5%, respectively (p < 0.05 vs. Lenti-NC). The KDM3A effects were further verified in VSMCs. HG (30mM)- and Ang II (1μM)-stimulated proliferation and migration of VSMCs was further enhanced in KDM3A overexpression group. However, the PCNA level, a proliferation index, was markedly blunted by KDM3A knockdown compared with Lenti-NC group (0.20 ± 0.02 vs. 0.15 ± 0.03, p < 0.05). Similar inhibitory effect of migration was also observed after KDM3A knockdown. Western blot indicated HG-induced expression of ROCK2 and downstream target p-MYPT-1 was further enhanced by KDM3A overexpression, but oppositely abolished by 41.4% and 31.9%, respectively, after knocking-down KDM3A (p < 0.05 vs. Lenti-NC). AGTR1 levels was also pronouncedly elevated after KDM3A overexpression, but blocked by 52.8% after KDM3A knockdown under 1μM Ang II stimulation (p < 0.05 vs. Lenti-NC); the downstream target ERK1/2 activity changed in the same tendency. More importantly, KDM3A knockdown increases H3K9m2 in the proximal promoter region of ROCK2 and AGTR1 genes in cultured VSMCs by Chip assay (p < 0.05 vs. Lenti-NC). Conclusions H3K9me2 may be a major underlying mechanism for vascular remolding in diabetes, and histone demethylase KDM3A may represent a promising therapeutic approach for the prevention of coronary artery disease combined with diabetes.

Inhibition of Polycomb Repressor Complex 2 Ameliorates Neointimal Hyperplasia by Suppressing Trimethylation of H3K27 in Vascular Smooth Muscle Cells.

Methyltransferase Like 3-Mediated N6-methylatidin Methylation Inhibits Vascular Smooth Muscle Cells Phenotype Switching Via Promoting Phosphatidylinositol 3-Kinase Mrna Decay.

The lysine methyltransferase SMYD2 facilitates neointimal hyperplasia by regulating the HDAC3–SRF axis

Critical Role of Histone Demethylase Jumonji Domain-Containing Protein 3 in the Regulation of Neointima Formation Following Vascular Injury

GW26-e4513 Histone Demethylase JMJD2A Inhibition Attenuates Neointimal Hyperplasia in the Carotid Arteries of Balloon-Injured Diabetic Rats Via Transcriptional Silencing: Inflammatory Gene Expression in Vascular Smooth Muscle Cells

GW24-e2386 Down-regulation of Histone Demethylase KDM3A Attenuates Balloon Injury-Induced Neointimal Hyperplasia in Diabetic Rats Through Modulation of Epigenetic Histone Lysine 9 Di-Methylation

Epigenetic regulation of vascular smooth muscle cell phenotypic switch and neointimal formation by PRMT5

Silencing epigenetic writer DOT1L attenuates intimal hyperplasia

SMYD3–PARP16 axis accelerates unfolded protein response and mediates neointima formation

H3K4 Methyltransferase Smyd3 Mediates Vascular Smooth Muscle Cell Proliferation, Migration, and Neointima Formation

Targeted Disruption of the Prostaglandin E2 E-prostanoid 2 Receptor Exacerbates Vascular Neointimal Formation in Mice.

P4HA2-induced prolyl hydroxylation of YAP1 restricts vascular smooth muscle cell proliferation and neointima formation

m6A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway

M 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia Via Activation of the P-Anxa2/stat3 Pathway

Inhibition of Neointimal Hyperplasia in the Rat Carotid Artery Injury Model by A Hmgb1 Inhibitor

Identification of PI3K regulatory subunit p55γ as a novel inhibitor of vascular smooth muscle cell proliferation and neointimal formation.

Regulation of Endothelial-to-mesenchymal Transition by Histone Deacetylase 3 Posttranslational Modifications in Neointimal Hyperplasia

Inhibitory effect of CP-25 on intimal formation and vascular hyperplasia via suppression of GRK2/ERK1/2/EVI1 signaling

WITHDRAWN: Smooth Muscle Cell-Specific Knockout of Interferon Gamma (Ifn-Γ) Receptor Attenuates Intimal Hyperplasia Via STAT1-KLF4 Activation

Sirt1 Acts As A Modulator of Neointima Formation Following Vascular Injury in Mice

Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats